SO
SOPHiA GENETICS S.A.
SOPH · NASDAQ
$8.19 -4.32% (-$0.37)
1M -3.08%
Market Cap $687.1M
P/E Ratio -
Div. Yield -
ROE 136.71%
Bulios Fair Price
$11.09
35.4% upside
Trenutna cena
$8.19
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SOPH trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
3 /100
Expensive P/B 8.27x
P/S 7.97x
PEG N/A
Growth
76 /100
Growing Book val. growth 38.24%
Rev. growth 17.56%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 52.95%
Op. margin 85.01%
Gross margin 66.63%
Quality
5 /100
Poor Asset turnover 0.43x
ROA 40.77%
ROIC 49.18%
Debt
54 /100
Moderate Current ratio 2.69x
Int. coverage -11.22x
Debt/Equity 0.74x
Stability
70 /100
Stable Profitable years 0
EPS volatility 23.49%
Beta 0.98x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SOPH
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ross Muken
Employees
415
Headquarters
Rolle
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report